Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-01-15
1989-06-20
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 55, 514 56, 514 60, 514 54, 536 20, 536 21, 536 51, 536 54, 536 58, A61K 3170, A61K 3172, A61K 31725, C08B 3702
Patent
active
048409413
ABSTRACT:
Method of treatment of diseases caused by retroviruses which comprises administering therapeutically effective amount of a natural or synthetic oligo- or polysaccharide having at least one S-oxoacid group attached to the saccharic carbon atom through a linking group of lower molecular weight or a pharmaceutically acceptable salt thereof to a subject in need of such treatment.
REFERENCES:
patent: 4374832 (1983-02-01), Joseph et al.
patent: 4522814 (1985-06-01), Nonomura et al.
patent: 4590181 (1986-05-01), McCarthy
patent: 4710493 (1987-12-01), Landsberger
patent: 4734403 (1988-03-01), Dussourd D'Ainterland
Solomon et al; J. Bacteriology, 92(6):1855-1856 (1966).
Kiehl et al; J. Nat. Cancer Inst. 51(5):1705-1707 (1973).
S. Chaffrath et al; Hoppe-Seyler's Z. Physiol. Chem. 357:499-498 (1976).
Ito et al; Antiviral Research, 7:361-367 (1987).
Hirose et al; Biochem. Biophys. Res. Commun. 149(2): 662-667 (1987).
Tochikura et al; Jpn. J. Cancer Res., 78:583-589 (1987).
Nakashima et al; Antimicrob. Agents Chemother., 31(10):1524-1528 (1987).
Sydow et al; Biomed. Biochem. ACTA, 46(6), 527-530 (1987).
Nagumo et al; Jpn. J. Cancer Res., 79:9-11 (1988).
Nakashima et al; Jpn. J. Cancer Res., 78:1164-1168 (1987).
DiCioccio et al, Cancer Research, 38, 2401-2407 (1978).
Ehlers et al, J. Gen Virol (1984), 65, 423-428 and 1325-1330.
Walton, British Journal Pharmacology, 7, 370 (1952), 8, 340 (1953) and 9, 1 (1954).
Ricketts, Biochem., 51, 129 (1952).
Kuno Sachiko
Tabata Akihiko
Ueno Ryuji
Ueno Ryuzo
Carson Nancy S.
Griffin Ronald W.
Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo
LandOfFree
Method for inhibiting infection of human T-cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting infection of human T-cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting infection of human T-cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-525494